The incidence and risk of cardiovascular events associated with immune checkpoint inhibitors in Asian populations

Abstract

Among Asians, immune checkpoint inhibitors were associated with an increased risk of major adverse cardiovascular events, particularly ischemic stroke and pulmonary embolism.